Business
Why the Mesoblast (ASX:MSB) share price is charging higher today – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is pushing higher on Monday after providing an update on its remestemcel-L for the treatment of SR-aGVHD…
The Mesoblast limited(ASX: MSB) share price has started the week strongly and is charging higher.
In early trade the allogeneic cellular medicines company’s shares are up 3% to $4.45.
Why is the Mesoblast share price pushing higher?
Investors have been buying the company’s shares this morning after its revealed results from a study of its remestemcel-L product in children with steroid-refractory acute graft versus host disease (SR-aGVHD).
According to the release, the results provide in vivo biomarker…
-
Noosa News21 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News23 hours agoFuel tanker racing to unload in Darwin ahead of Tropical Cyclone Fina
-
Noosa News22 hours agoShattered families demand justice after Wieambilla killers not deemed terrorists
-
Noosa News20 hours agoSeven key takeaways from the Queensland probe’s first week